3/26
08:14 am
eras
Erasca, Inc. (NASDAQ: ERAS) is now covered by analysts at Raymond James. They set an "outperform" rating and a $5.00 price target on the stock.
Medium
Report
Erasca, Inc. (NASDAQ: ERAS) is now covered by analysts at Raymond James. They set an "outperform" rating and a $5.00 price target on the stock.
3/25
04:31 pm
eras
Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting
Neutral
Report
Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting
3/21
10:07 am
eras
Erasca, Inc. (NASDAQ: ERAS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $3.50 to $3.00. They now have a "buy" rating on the stock.
Low
Report
Erasca, Inc. (NASDAQ: ERAS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $3.50 to $3.00. They now have a "buy" rating on the stock.
3/21
08:20 am
eras
Erasca, Inc. (NASDAQ: ERAS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
Erasca, Inc. (NASDAQ: ERAS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/20
04:01 pm
eras
Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results
Medium
Report
Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results
3/7
12:54 pm
eras
Erasca, Inc. (NASDAQ: ERAS) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $4.00 price target on the stock.
Low
Report
Erasca, Inc. (NASDAQ: ERAS) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $4.00 price target on the stock.
1/31
08:00 am
eras
Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference
Low
Report
Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference
1/28
08:03 am
eras
https://seekingalpha.com/article/4752497-erasca-future-streamlined-but-still-uncertain [Seeking Alpha]
Medium
Report
https://seekingalpha.com/article/4752497-erasca-future-streamlined-but-still-uncertain [Seeking Alpha]
11/12/2024
04:01 pm
ERAS
erasca, inc.
BEAT
Report
-4.7%
erasca, inc.
8/12/2024
04:01 pm
ERAS
erasca, inc.
MISS
Report
-3.3%
erasca, inc.
8/12/2024
04:01 pm
ERAS
erasca, inc.
MISS
Report
-3.3%
erasca, inc.
8/12/2024
04:01 pm
ERAS
erasca, inc.
MISS
Report
0.4%
erasca, inc.
4/15
03:56 pm
eras
Form 144 Erasca, Inc. Filed by: Erasca Foundation
Low
Report
Form 144 Erasca, Inc. Filed by: Erasca Foundation
3/20
04:20 pm
eras
Form 10-K Erasca, Inc. For: Dec 31
Medium
Report
Form 10-K Erasca, Inc. For: Dec 31
3/20
04:10 pm
eras
Form 8-K Erasca, Inc. For: Mar 20
Low
Report
Form 8-K Erasca, Inc. For: Mar 20
3/17
04:42 pm
eras
Form 144 Erasca, Inc. Filed by: Erasca Foundation
Low
Report
Form 144 Erasca, Inc. Filed by: Erasca Foundation
2/18
03:57 pm
eras
Form 144 Erasca, Inc. Filed by: Erasca Foundation
Low
Report
Form 144 Erasca, Inc. Filed by: Erasca Foundation
2/18
09:00 am
eras
Form 4 Erasca, Inc. For: Feb 13 Filed by: Garner Ebun
Medium
Report
Form 4 Erasca, Inc. For: Feb 13 Filed by: Garner Ebun
2/13
08:10 pm
eras
Form SCHEDULE 13G/A Erasca, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Medium
Report
Form SCHEDULE 13G/A Erasca, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
2/12
05:02 pm
eras
Form SCHEDULE 13G/A Erasca, Inc. Filed by: NOVARTIS PHARMA AG
Medium
Report
Form SCHEDULE 13G/A Erasca, Inc. Filed by: NOVARTIS PHARMA AG
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register